In the Boardroom
Refine Search
Pharmaceutical
Danish drugmaker LEO Pharma today announced that it appointed Chris Posner as executive vice president Region US and president and chief executive LEO Pharma Inc. 23 June 2017
Pharmaceutical
US fertility treatment specialist OvaScience will cut its workforce and appoint a new chief executive, Christopher Kroeger, in a bid to slow the company’s cash burn rate and focus on key clinical development goals. 22 June 2017
Pharmaceutical
In a battle which commentators might observe embodies a wider conflict of its time, the row engulfing Netherlands-incorporated drugmaker Mylan has entered another ugly round. 13 June 2017
Pharmaceutical
Mylan is fighting battles on multiple fronts, including over price increases of its EpiPen (epinephrine) devices and as it races to market with its biosimilar products. 7 June 2017
Pharmaceutical
Privately-held Swiss firm Ferring Pharmaceuticals today announced that Paul Navarre has been appointed chief executive of Ferring Holding Inc. 2 June 2017
Pharmaceutical
Sweden-based specialty pharma company Pharmalink has announced the appointment of Renee Aguiar-Lucander as its new chief executive. 18 May 2017
Pharmaceutical
UK-based GW Pharmaceuticals has appointed Volker Knappertz as chief medical officer (CMO). 15 May 2017
Pharmaceutical
Germany’s Merck KGaA has appointed Constantin Birnstiel as head of group communications. 12 May 2017
Pharmaceutical
Japan’s Astellas Pharma has promoted Shontelle Dodson to senior vice president and head of medical affairs Americas, effective May 15, 2017. Ms Dodson previously served as vice president of medical excellence within the global medical affairs organization. 12 May 2017
Pharmaceutical
German family-owned drugmaker Grünenthal has appointed Mark Fladrich to the position of chief commercial officer (CCO) responsible for the firm’s entire global commercial organization. 9 May 2017
Pharmaceutical
Bayer hA appointed Bhavesh Ashar as senior vice president and head of oncology for the company's Pharmaceuticals Division in the USA, reporting to Carsten Brunn, head of Bayer Pharmaceuticals for the Americas region. 3 May 2017
Pharmaceutical
In the midst of a comprehensive cost cutting program rumored to include thousands of job losses, Teva chief financial officer Eyal Desheh is about to quit, Israeli press reports. 3 May 2017
Pharmaceutical
Recently-floated PLx Pharma has made two new executive appointments, hiring Rita O’Connor as chief financial officer and Michael Dillon as vice president of sales and marketing. 3 May 2017
Pharmaceutical
Sweden’s Karolinska Development says that Bo Jesper Hansen, chairman of the company's board, has decided not stand for re-election at the 2017 Annual General Meeting. 20 April 2017
Pharmaceutical
French drugmaker Ipsen on Friday announced the appointment of Dr Alexandre Lebeaut as executive vice-president, R&D, and chief scientific officer, effective immediately. 18 April 2017
Pharmaceutical
In a finding that might add weight to industry calls for continued free movement of vital talent post-Brexit, a study has shown that country managers and European heads in UK pharma are far more internationally diverse than their French and German counterparts. 12 April 2017
Pharmaceutical
Takeda Pharmaceuticals says that Ricardo Marek has been appointed as the president of the Emerging Markets Business Unit (EM BU), based in Singapore, effective April 1, 2017 31 March 2017
Pharmaceutical
Takeda Pharmaceutical said today that Giles Platford will assume the role of president of its Europe and Canada (EUCAN) business unit. In this role he will lead business operations in the region effective April 1, 2017. 30 March 2017
Pharmaceutical
Claude Bertrand started on Monday in his new role as general director of research and development (R&D) and chief scientific officer (CSO) at privately-held French drugmaker Servier. 27 March 2017
Pharmaceutical
The US subsidiary of Japanese pharma major Eisai has appointed Kirk Shepard as senior vice president, global medical affairs of the Oncology Business Group. 17 March 2017
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze